docetaxel anhydrous has been researched along with Oropharyngeal Neoplasms in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (29.63) | 29.6817 |
| 2010's | 16 (59.26) | 24.3611 |
| 2020's | 3 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bouganim, N; Fuson, A; Joshi, AS; Khalife, S; Mascarella, MA; Ramanakumar, AV; Richardson, K; Sadeghi, N; Siegel, R; Taheri, R | 1 |
| Brizel, DM; Choudhury, KR; Das, S; Mowery, YM; Niedzwiecki, D; Rushing, CN; Vergalasova, I; Wong, TZ; Wu, Q; Yoo, DS | 1 |
| Borah, BJ; Chintakuntlawar, AV; Foote, RL; Garces, YI; Garcia, JJ; Graner, DE; Hallemeier, CL; Hinni, ML; Janus, JR; Kasperbauer, JL; Ma, DJ; May, JM; Miller, RC; Moore, EJ; Neben-Wittich, MA; Patel, SH; Price, DL; Price, KA; Visscher, SL; Waddle, MR | 1 |
| Dietz, A; Görner, M; Grosse-Thie, C; Guntinas-Lichius, O; Inhestern, J; Jungehülsing, M; Kuhnt, T; Maschmeyer, G; Rotter, N; Schmalenberg, H; Sudhoff, H; Wittekindt, C | 1 |
| Enomoto, M; Ishizaki, T; Kasuya, K; Katsumata, K; Kuwahara, H; Matsudo, T; Murakoshi, Y; Shigoka, M; Tsuchida, A; Wada, T | 1 |
| Chintakuntlawar, AV; Foote, RL; Foster, NR; Garces, YI; Garcia, JJ; Ginos, B; Graner, DE; Hinni, ML; Janus, JR; Kasperbauer, JL; Ma, DJ; Miller, R; Moore, EJ; Neben-Wittich, M; Olsen, KD; Patel, SH; Price, DL; Price, KA; Shiraishi, S; Van Abel, KM; Waddle, M | 1 |
| Bossi, P; Cortelazzi, B; Fallai, C; Gloghini, A; Granata, R; Guzzo, M; Licitra, L; Locati, L; Mariani, L; Miceli, R; Orlandi, E; Perrone, F; Pilotti, S; Scaramellini, G | 1 |
| Albert, S; Antoine, M; Banal, A; Baril, P; Belloc, JB; Benetkiewicz, M; Bonnetain, F; Céruse, P; Chabolle, F; Chibaudel, B; de Gramont, A; Gatineau, M; Housset, M; Lacau St Guily, J; Lacave, R; Lefevre, M; Moukoko, R; Périé, S; Soussan, P | 1 |
| Inohara, H; Isohashi, F; Nakahara, S; Ogawa, K; Seo, Y; Sumida, I; Suzuki, O; Takenaka, Y; Tomiyama, Y; Yamamoto, Y; Yoshii, T; Yoshioka, Y | 1 |
| Chan, KK; Furness, S; Glenny, AM; Wakeford, H; Weldon, JC; Worthington, HV | 1 |
| Ando, M; Asakage, T; Omura, G; Saito, Y; Yamasoba, T; Yoshida, M | 1 |
| Alfieri, S; Bergamini, C; Bossi, P; Cavallo, A; Cova, A; Granata, R; Huber, V; Iacovelli, NA; Imbimbo, M; Licitra, L; Locati, L; Mariani, L; Miceli, R; Orlandi, E; Resteghini, C; Rivoltini, L | 1 |
| Bhandari, M; Jones, RG; Kang, SY; Seim, NB; Teknos, TN | 1 |
| Fujii, M; Fukada, J; Kawaguchi, O; Kubo, A; Kunieda, E; Ohashi, T; Shigematsu, N; Shiotani, A; Takeda, A; Tomita, T | 1 |
| Ehara, S; Nakamura, R; Nakasato, T; Nishimura, K; Oikawa, H; Sato, H | 1 |
| Chilimoniuk, M; Maksimowicz, T; Olszewska, E | 1 |
| Debus, J; Desta, A; Habl, G; Jensen, AD; Krauss, J; Mavtratzas, A; Münter, MW; Potthoff, K; Windemuth-Kiesselbach, C | 1 |
| Cianchetti, M; Forastiere, A; Gunn, GB; Marur, S; McNutt, T; Rao, N; Ricchetti, F; Sanguineti, G; Sormani, MP; Wu, B | 1 |
| Annino, DJ; Balboni, TA; Goguen, LA; Haddad, RI; Lorch, J; Norris, CM; Posner, MR; Sher, DJ; Thotakura, V; Tishler, RB | 1 |
| Dietz, A; Guntinas-Lichius, O; Kuhnt, T; Maschmeyer, G; Oertel, K; Schmalenberg, H; Spiegel, K; Sudhoff, H; Wendt, TG | 1 |
| Alfonsi, M; Auvray, H; Bardet, E; Bourhis, J; Calais, G; Garaud, P; Man, YT; Rhein, B; Sire, C; Tortochaux, J | 1 |
| Taniguchi, M; Watanabe, A | 2 |
| Kovács, AF | 1 |
| Eberlein, K; Kovács, AF; Rohde, S; Smolarz, A; Weidauer, S | 1 |
| Fujii, M; Fujii, R; Ogawa, K; Ozawa, H; Sakamoto, K; Shinden, S; Tomita, T; Yamashita, T | 1 |
| Kovács, AF; Schiemann, M; Turowski, B | 1 |
2 review(s) available for docetaxel anhydrous and Oropharyngeal Neoplasms
| Article | Year |
|---|---|
Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Docetaxel; ErbB Receptors; Gefitinib; Humans; Immunotherapy; Lapatinib; Molecular Targeted Therapy; Mouth Neoplasms; Oropharyngeal Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Randomized Controlled Trials as Topic; Taxoids | 2015 |
[Planned neck dissection after weekly docetaxel and concurrent radiotherapy for advanced oropharyngeal cancer].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Elective Surgical Procedures; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Oropharyngeal Neoplasms; Prognosis; Radiotherapy, Adjuvant; Taxoids | 2007 |
10 trial(s) available for docetaxel anhydrous and Oropharyngeal Neoplasms
| Article | Year |
|---|---|
Early
Topics: Analysis of Variance; Antineoplastic Agents; Cisplatin; Docetaxel; Female; Fluorodeoxyglucose F18; Human papillomavirus 16; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Tumor Burden | 2020 |
Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the Oropharynx.
Topics: Antineoplastic Agents; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Cost Savings; Costs and Cost Analysis; Docetaxel; Dose Fractionation, Radiation; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Postoperative Period; Prospective Studies; Quality of Life; Radiotherapy, Adjuvant; Squamous Cell Carcinoma of Head and Neck; Surgical Procedures, Operative | 2021 |
A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patien
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deglutition; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Postoperative Care; Quality of Life; Survival Analysis; Taxoids | 2017 |
Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell Carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Combined Modality Therapy; Cyclin-Dependent Kinase Inhibitor p16; Deglutition; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Radiation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Postoperative Period; Prospective Studies; Quality of Life; Radiation Dosage; Self Report; Smoking; Treatment Outcome | 2019 |
Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Oropharyngeal Neoplasms; Taxoids; Treatment Outcome | 2015 |
Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; DNA, Viral; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Organ Sparing Treatments; Oropharyngeal Neoplasms; Papillomaviridae; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Stomatitis; Survival Rate; Taxoids | 2015 |
Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx--TPF-C-HIT.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carbon; Cetuximab; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Genetic Testing; Humans; Hypopharyngeal Neoplasms; Ions; Laryngeal Neoplasms; Oropharyngeal Neoplasms; Radioimmunotherapy; Taxoids | 2011 |
Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Mouth Neoplasms; Neoplasm Grading; Neoplasm Staging; Oropharyngeal Neoplasms; Taxoids; Treatment Outcome | 2012 |
Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Dose Fractionation, Radiation; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Prospective Studies; Radiation-Sensitizing Agents; Survival Analysis; Taxoids | 2004 |
Combined modality treatment of oral and oropharyngeal cancer including neoadjuvant intraarterial cisplatin and radical surgery followed by concurrent radiation and chemotherapy with weekly docetaxel - three year results of a pilot study.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Cranial Irradiation; Docetaxel; Dose Fractionation, Radiation; Drug Tolerance; Feasibility Studies; Female; Humans; Injections, Intra-Arterial; Lymph Node Excision; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Patient Compliance; Pilot Projects; Prognosis; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Survival Analysis; Taxoids | 2002 |
15 other study(ies) available for docetaxel anhydrous and Oropharyngeal Neoplasms
| Article | Year |
|---|---|
Pathologic response to neoadjuvant chemotherapy in HPV-associated oropharynx cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Female; Humans; Neoadjuvant Therapy; Oropharyngeal Neoplasms; Papillomavirus Infections; Treatment Outcome | 2020 |
[Two Cases of Non-Occlusive Mesenteric Ischemia That Developed after Chemotherapy].
Topics: Aged; Antineoplastic Agents; Docetaxel; Humans; Intestinal Diseases; Male; Mesenteric Ischemia; Oropharyngeal Neoplasms; Prostatic Neoplasms; Taxoids | 2017 |
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Cyclin-Dependent Kinase Inhibitor p16; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Retrospective Studies; Taxoids; Tertiary Care Centers; Treatment Outcome | 2014 |
[Retrospective Study of Induction Chemotherapy and Concurrent Chemoradiation Therapy for Oropharyngeal Cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Retrospective Studies; Taxoids; Treatment Outcome | 2015 |
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Cytokines; Docetaxel; Dose Fractionation, Radiation; Fluorouracil; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Interleukin-1beta; Interleukin-6; Laryngeal Neoplasms; Mouth Neoplasms; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Prospective Studies; Radiotherapy, Intensity-Modulated; Saliva; Severity of Illness Index; Stomatitis; Taxoids; Time Factors; Tumor Necrosis Factor-alpha | 2016 |
Personalized Medicine Approach for an Exceptional Response to Multiple-recurrent and Metastatic HER2-positive Oropharyngeal Squamous Cell Carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Docetaxel; Fluorouracil; Humans; Induction Chemotherapy; Lung Neoplasms; Lymph Nodes; Magnetic Resonance Imaging; Male; Mediastinum; Middle Aged; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Precision Medicine; Radiotherapy, Intensity-Modulated; Receptor, ErbB-2; Taxoids; Tomography, X-Ray Computed; Trastuzumab | 2017 |
Weekly low-dose docetaxel-based chemoradiotherapy for locally advanced oropharyngeal or hypopharyngeal carcinoma: a retrospective, single-institution study.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cause of Death; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Mucositis; Neoadjuvant Therapy; Neoplasm Staging; Oropharyngeal Neoplasms; Radiotherapy Dosage; Retrospective Studies; Taxoids | 2010 |
Radiotherapy and concomitant intra-arterial docetaxel combined with systemic 5-fluorouracil and cisplatin for oropharyngeal cancer: a preliminary report--improvement of locoregional control of oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Leukopenia; Male; Middle Aged; Mucositis; Oropharyngeal Neoplasms; Radiodermatitis; Radiotherapy Dosage; Remission Induction; Taxoids | 2009 |
[Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results].
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Diarrhea; Docetaxel; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasms, Squamous Cell; Neutropenia; Oropharyngeal Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome; Vomiting | 2010 |
Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Cisplatin; Confidence Intervals; Dasatinib; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Mouth Mucosa; Odds Ratio; Organs at Risk; Oropharyngeal Neoplasms; Pyrimidines; Radiography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Stomatitis; Taxoids; Thiazoles; Tumor Burden | 2012 |
Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy.
Topics: Aged; Albumin-Bound Paclitaxel; Albumins; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorouracil; Human papillomavirus 16; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Oropharyngeal Neoplasms; Paclitaxel; Panitumumab; Papillomavirus Infections; Proportional Hazards Models; Radiation Tolerance; Radiotherapy, Intensity-Modulated; Retrospective Studies; Taxoids; Treatment Failure | 2012 |
[Metastatic oropharyngeal cancer successfully treated with docetaxel, cisplatin, 5-FU and l-leucovorin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Drug Administration Schedule; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Male; Oropharyngeal Neoplasms; Remission Induction; Taxoids | 2004 |
[A case of oropharyngeal cancer with multiple bone metastases from prostate cancer that responded to docetaxel, ifosfamide and cisplatin combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Drug Administration Schedule; Humans; Ifosfamide; Infusions, Intravenous; Male; Oropharyngeal Neoplasms; Prostatic Neoplasms; Quality of Life; Taxoids | 2005 |
Maximized combined modality treatment of an unselected population of oral and oropharyngeal cancer patients. Final results of a pilot study compared with a treatment-dependent prognosis index.
Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Docetaxel; Epidemiologic Methods; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Squamous Cell; Oropharyngeal Neoplasms; Prognosis; Recurrence; Survival Rate; Taxoids; Treatment Outcome; Treatment Refusal | 2006 |
[Organ-preserving treatment in inoperable patients with primary oral and oropharyngeal carcinoma: chances and limitations].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Palliative Care; Radiotherapy, Adjuvant; Retreatment; Survival Rate; Taxoids | 2006 |